Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER

por Böldicke, Thomas
Publicado 2007

Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions

por Böldicke, Thomas
Publicado 2022

Specific in vivo knockdown of protein function by intrabodies

por Marschall, Andrea LJ, Dübel, Stefan, Böldicke, Thomas
Publicado 2015

Intrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cells

por Somplatzki, Stefan, Mühlenhoff, Martina, Kröger, Andrea, Gerardy-Schahn, Rita, Böldicke, Thomas
Publicado 2017

Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation

por Kirschning, Carsten J, Dreher, Stefan, Maaß, Björn, Fichte, Sylvia, Schade, Jutta, Köster, Mario, Noack, Andreas, Lindenmaier, Werner, Wagner, Hermann, Böldicke, Thomas
Publicado 2010

Molecular cloning and characterization of a novel anti-TLR9 intrabody

por Reimer, Elisa, Somplatzki, Stefan, Zegenhagen, Diana, Hänel, Svenja, Fels, Alina, Bollhorst, Thorsten, Hovest, Ludger Grosse, Bauer, Stefan, Kirschning, Carsten J., Böldicke, Thomas
Publicado 2013

ER intrabody-mediated inhibition of interferon α secretion by mouse macrophages and dendritic cells

por Büssow, Konrad, Themann, Philipp, Luu, Sabine, Pentrowski, Paul, Harting, Claudia, Majewski, Mira, Vollmer, Veith, Köster, Mario, Grashoff, Martina, Zawatzky, Rainer, Van den Heuvel, Joop, Kröger, Andrea, Böldicke, Thomas
Publicado 2019